Connecticut’s Two Leading Health Systems Partner to Bring New Cancer Treatment to State

Print icon

Hartford HealthCare (HHC) and Yale New Haven Health System (YNHHS) today announced a plan to work together to bring proton beam therapy — a highly advanced form of radiation treatment for cancer – to Connecticut. HHC and YNHHS will seek approval from the state Office of Health Strategy to move forward with the project, which would include construction of a 25,000-square-foot proton therapy center at 932 Northrop Road in Wallingford.

The highly targeted radiological treatment uses protons rather than X-rays to treat cancer, and is only available at a handful of locations in the Northeast – none of them in Connecticut.

The two health systems selected Proton International (PI) as project manager and operator for the proposed proton facility. PI is an established and experienced developer and operator of proton centers throughout the country having helped to develop and operate multiple centers nationwide.

“Yale New Haven Health is proud and excited to bring this highly innovative technology to patients in Connecticut,” said Richard D’Aquila, President of Yale New Haven Health and Yale New Haven Hospital. “Our unique collaboration with HHC will allow us to care for patients with cancer in a new and effective way by bringing a life-changing therapy to our state.”

“This is a historic moment for cancer care in Connecticut,” said Hartford HealthCare President and Chief Executive Officer Jeffrey A. Flaks. “This is a truly innovative partnership that will bring our patients access to the most advanced treatment in the world, close to home.”

Proton therapy is a type of radiation therapy that uses a high energy beam of protons to irradiate cancer. The chief advantage of proton therapy over other types of radiotherapy is that the dose is more finely controlled. With proton beam, there is less entry, exit, and scattered radiation so that physicians can safely deliver higher doses of radiation to tumors with fewer side effects.

Proton therapy is appropriate for many solid cancer tumors, including tumors of the brain and central nervous system, eye, gastrointestinal tract, head and neck, liver, lung, prostate, spine and some breast tumors. It is particularly beneficial for children, as they are more vulnerable to damage to healthy tissue from radiation.

As proposed, the Wallingford center would include the latest technology and equipment; treatment room; control room; exam rooms and clinical space. Employees will include physicians and clinical staff from YNHH and HHC, as well as additional new staff.

“We are very proud to host this innovative partnership between Hartford HealthCare and Yale New Haven Health,” said Wallingford Mayor William Dickinson. “It’s so exciting that we will have cancer treatment of this caliber so easily accessible, right here in Wallingford. Not having to drive out of state to get proton therapy treatment will be such a blessing to so many people.”


What's New

Dr. Khalid M. Abbed

Renowned Spine Care Neurosurgeon joins Hartford HealthCare in Southwestern Connecticut

BRIDGEPORT —Hartford HealthCare announces the appointment of Dr. Khalid M. Abbed, one of New England’s leading neurosurgeons, as Co-Physician-in-Chief of its Ayer Neuroscience Institute. An experienced neurosurgeon and hospital director with a demonstrated history of leadership in the healthcare industry, he will oversee neurosurgical services and lead the Ayer Neuroscience...


HHC Neurology Services expand to Thomaston

The Hartford HealthCare Ayer Neuroscience Institute at Charlotte Hungerford Hospital has recently welcomed Nabi Chowdhury, MD, who is now accepting patients one day a week at the new CHH Specialty Care office located at 76 Watertown Road, Thomaston. The practice offers neurological evaluations, diagnosis and treatment of diseases and disorders...

Epilepsy

How Specialty Care Can Lower Risk of Death From Epilepsy

Patients getting epilepsy care in a specialty center had a lower chance of death, according to a Canadian study released in the Journal of the American Medical Society Neurology. Dr. Gabriel Martz, director of The Epilepsy Center at Hartford HealthCare’s Ayer Neuroscience Institute, said in some cases the challenges of...

Dr. Elena Bortan

Movement Disorders Care Comes to Mystic

Much as the design of the new Hartford HealthCare facility at 100 Perkins Farms Drive in Mystic reflects the vibe of coastal community, the location of specialists from the HHC Ayer Neuroscience Institute’s Chase Family Movement Disorders Center to the facility answers a demand for high-quality care and support in...

Ozzy Osbourne

How Physical Therapy Might Help Ozzy Osbourne, Other Parkinson’s Patients

For years, substance abuse might have been the presumed root of shaking and stumbling by rock star Ozzy Osbourne, but the 71-year-old rocker recently revealed that Parkinson’s disease is to blame. Parkinson’s, a chronic and progressive movement disorder for which there is treatment but no cure, affects more than 200,000...